惠泰医疗: 公司章程

General Information - The company is named Shenzhen Huitai Medical Equipment Co., Ltd. and was established through the overall change of Shenzhen Huitai Medical Equipment Co., Ltd. [2] - The company was registered with a capital of RMB 141,013,796 and is a permanent corporation [2][3] - The company was approved for listing on the Shanghai Stock Exchange's Sci-Tech Innovation Board on September 8, 2020, and officially listed on January 7, 2021, with an initial public offering of 16.67 million shares [2] Business Objectives and Scope - The company's business objective is to focus on independent innovation and development in the field of vascular minimally invasive intervention, contributing significantly to global healthcare [2] - The business scope includes the production, operation, and leasing of various classes of medical devices, as well as technology services and development [2] Share Structure - The total number of shares issued by the company is 141,013,796, all of which are ordinary shares [3] - The company’s shares are issued in the form of stocks, and each share of the same category has equal rights [3][4] Shareholder Rights and Responsibilities - Shareholders have the right to participate in shareholder meetings, receive dividends, and request information about the company [5][6] - Shareholders are obligated to comply with laws and regulations, pay for their subscribed shares, and not abuse their rights to harm the company or other shareholders [8][9] Governance Structure - The company is governed by a board of directors, with the chairman serving as the legal representative [2][3] - The company has established an audit committee to oversee compliance and financial integrity [8] Shareholder Meetings - The company holds annual and temporary shareholder meetings, with specific procedures for calling and conducting these meetings [12][13] - Shareholders holding more than 10% of the shares can request the board to convene a temporary meeting [13][14] Financial Management - The company can increase its capital through various methods, including issuing shares to unspecified or specific targets [3][4] - The company is restricted from repurchasing its shares except under certain conditions, such as capital reduction or employee stock ownership plans [3][4] Compliance and Legal Framework - The company adheres to the Company Law and Securities Law of the People's Republic of China, ensuring that all operations are compliant with relevant regulations [2][5] - The company is required to disclose significant transactions and maintain transparency with shareholders [10][11]